Focuses on progress in research on the treatment of Alzheimer's disease. Symptomatic treatments' function of correcting neurotransmitter deficits that arise when brain cells die; Side effects of tacrine and related drugs; European researchers endorsement of the nootropics class of drugs; Attempts being ...
Scientists at the University of Liverpool have created a new chemical compound that could be developed into a drug treatment for Alzheimer’s disease. The research team has used a family of long chain sugars called Heparan Sulphates (HS), found on nearly every cell of the body, to produce a...
The results of three new studies indicate there could be new treatments for Alzheimer's and stroke. One study reveals a possible link between gum disease and Alzheimer's. Two other studies explore how the substance sovateltide shows promise for treating neurodegenerative disorders. The research data...
The resultant decrease in ACh-dependent neurotransmission is thought to lead to the functional deficits of AD, much as dopaminergic deficits underlie Parkinson disease and its clinical manifestations.[23] Butyrylcholinesterase (BuChE) is an enzyme, like AChE, that degrades ACh. Whereas BuChE is ...
New therapies for early Alzheimer's disease, monoclonal antibodies that remove amyloid-β plaques in the brain, are bringing hope to people whose lives have been affected by the disease. To help neurologists discuss these therapies with patients and care
/PRNewswire/ -- AstronauTx Ltd. ("AstronauTx"), a biotech company developing novel treatments for Alzheimer's disease and other neurodegenerative disorders,...
摘要: Reviews evidence on efficacy of donepezil and rivastigmine in Alzheimer's disease, including side effects, and on managing behavioural disturbances in dementia using complementary medicine. Includes case study. DOI: http://www.nps.org.au/publications/health-professional/nps-news/ 收藏...
根据第二段The brain science behind Alzheimer's is complex,but CT and MRI scans suggest that poisonous changes occur in the brain,including the abnormal buildup of proteins called amyloid plaques and tau tangles.(阿尔茨海默氏症背后的脑科学是复杂的,但CT和MRI扫描表明,大脑中发生了...
Successful development of agents that improve cognition and behavior in Alzheimer’s disease (AD) is critical to improving the lives of patients manifesting the symptoms of this progressive disorder. There have been no recent approvals of cognitive enhan
“The method allows us to monitor disease-related changes at an earlier stage than is possible with traditional methods. And this is important when it comes to Alzheimer’s because it’s known to develop over a very long period of time. This is also why...